{"favorite_id": 10334, "calc_type": "diagnostic_criteria", "dosing": false, "full_title_en": "Rome IV Diagnostic Criteria for Child Functional Dyspepsia", "short_title_en": "Rome IV for Child Dyspepsia", "medium_description_en": "Official Rome IV criteria for the diagnosis of child functional dyspepsia.", "short_description_en": "Child dyspepsia diagnosis.", "before_use": "", "instructions_en": "<p dir=\"ltr\">Use in a child or adolescent with symptoms suggestive of functional dyspepsia for at least 2 months. The diagnosis of functional dyspepsia should be made by clinical history, positive symptom criteria, physical examination, minimal diagnostic testing as clinically indicated.&nbsp;&nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following alarm features must be evaluated clinically for other diagnoses even though functional dyspepsia may be present:</p>\n<p><span id=\"docs-internal-guid-3e2e5447-7fff-9e19-fac2-8cf93506efc5\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent right upper or right lower quadrant pain.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Odynophagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Gastrointestinal blood loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Nocturnal pain or diarrhea.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Arthritis.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Perirectal disease.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Involuntary weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Deceleration of linear growth.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Delayed puberty.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained fever.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of inflammatory bowel disease, celiac disease, or peptic ulcer disease.</p>\n</li>\n</ul>", "purpose_en": ["Diagnosis"], "disease_en": ["Child/Adolescent Functional GI Disorders", "Disorders of Gut-Brain Interaction (DGBI)"], "specialty_en": ["Family Practice", "Gastroenterology", "Hospitalist Medicine", "Internal Medicine", "Primary Care"], "chief_complaint_en": ["Nausea", "Vomiting", "Heartburn"], "system_en": ["Gastrointestinal"], "search_abbreviation_en": ["Rome IV Criteria for Child Functional Dyspepsia, Rome IV for Child Dyspepsia, rome iv child functional dyspepsia, rome iv functional dyspepsia, rome iv dyspepsia, rome 4 child functional dyspepsia, rome 4 functional dyspepsia, rome 4 dyspepsia, rome dyspepsia, rome child dyspepsia, rome, child dyspepsia, functional dyspepsia, dyspepsia"], "slug": "rome-iv-diagnostic-criteria-child-functional-dyspepsia", "seo": {"meta_description_en": "The Rome IV Criteria for Child Functional Dyspepsia provides criteria for diagnosis of child functional dyspepsia.", "keywords_en": "Rome IV Criteria for Child Functional Dyspepsia, Rome IV for Child Dyspepsia, rome iv child functional dyspepsia, rome iv functional dyspepsia, rome iv dyspepsia, rome 4 child functional dyspepsia, rome 4 functional dyspepsia, rome 4 dyspepsia, rome dyspepsia, rome child dyspepsia, rome, child dyspepsia, functional dyspepsia, dyspepsia"}, "content": {"how_to_use": {"use_case_en": "<p><span id=\"docs-internal-guid-06461c45-7fff-7b12-a00f-434772904299\">Children and adolescents presenting with recurrent upper gastrointestinal symptoms suggestive of dyspepsia such as chronic and recurrent epigastric pain or burning not associated with defecation, postprandial fullness, early satiety, upper abdominal bloating, nausea and/or excessive belching for at least 2 months. </p>", "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-d842af7c-7fff-d344-63df-5b71b2e98842\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">The diagnosis of&nbsp; functional dyspepsia (FD) is a positive diagnosis, and not a diagnosis of exclusion. It should be evaluated and treated in the context of the biopsychosocial model.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">There are two subtypes of FD each with its own criteria: postprandial distress syndrome, which is related to meals, and epigastric pain syndrome, which may or may not be related to meals.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">A negative EGD is not needed to make the diagnosis of pediatric functional dyspepsia (unlike in adults).&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unlike in adults, the association of H. pylori gastritis and pediatric FD has not been well established. Therefore, routine screening for H. pylori in children with FD is currently not indicated.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Symptoms of FD often overlap with gastroesophageal reflux disease, gastroparesis, <calculator id=\"10331\">functional constipation</calculator>, and <calculator id=\"10328\">irritable bowel syndrome</calculator>, which should be addressed.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Anxiety is higher in children with FD compared to those without dyspepsia, both in the short and long-term.</p>\n</li>\n</ul>", "why_use_en": "<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Used to establish the diagnosis of functional dyspepsia in children and adolescents who present with recurrent or chronic epigastric pain or bothersome postprandial symptoms.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Can be used to discuss the diagnosis of functional dyspepsia with patients and initiate treatment based on FD subtypes.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\"><span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">Making a diagnosis will help minimize unnecessary diagnostic evaluations and allow early, targeted treatment.<span style=\"font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;\">&nbsp;&nbsp;</p>\n</li>\n</ul>"}, "next_steps": {"advice_en": "<p dir=\"ltr\"><strong>If diagnosis not met (negative):</strong></p>\n<p dir=\"ltr\">Current symptoms are unlikely to be related to functional dyspepsia. Consider further assessment as clinically indicated. Also, see pearls and pitfalls above.&nbsp;</p>\n<p dir=\"ltr\"><strong>If meets diagnosis (positive):</strong></p>\n<p><span id=\"docs-internal-guid-4bb9a95d-7fff-a411-defb-ad5144cd2c85\"></p>\n<p dir=\"ltr\">Likely diagnosis of functional dyspepsia. Determine the subtype and consider initiating treatment.</p>", "management_en": "<p dir=\"ltr\">Management of both functional dyspepsia subtypes include:&nbsp;</p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Education about the diagnosis and the current understanding of disorders of the gut-brain interaction, providing reassurance.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dietary changes can be tried as a first step: smaller meals, avoidance of fatty meals, spicy foods, and carbonated beverages as well as avoidance of nonsteroidal anti-inflammatory agents.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Addressing anxiety or psychological stressors as the cause or result of the gastrointestinal symptoms.</p>\n</li>\n</ol>\n<p dir=\"ltr\">Further management is primarily supportive and may vary depending on the subtype.</p>\n<p dir=\"ltr\">For postprandial distress syndrome (PDS):</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Cyproheptadine.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Prokinetics&nbsp; (e.g. erythromycin, prucalopride, cisapride*, domperidone*, metoclopramide*).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Buspirone.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Mirtazapine.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Antiemetics (e.g. Ondansetron, prochlorperazine, promethazine, diphenhydramine).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Psychological treatments (e.g. CBT, hypnosis, mindfulness).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Herbal treatments (e.g. Iberogast, caraway and peppermint oil based formulations).&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Neurostimulator (IB-Stim).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Botulinum toxin to pylorus..</p>\n</li>\n</ul>\n<p dir=\"ltr\">For epigastric pain syndrome (EPS):</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Short term PPI or H2 blockers.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Cyproheptadine.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Pain modulators such as gabapentin or pregabalin, tricyclic antidepressants (e.g. Amitriptyline).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Psychological treatments (e.g. CBT, hypnosis, mindfulness).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Herbal treatments (e.g. Iberogast, caraway and peppermint oil based formulations).&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Neurostimulator (IB-Stim).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Botulinum toxin to pylorus.</p>\n</li>\n</ul>\n<p dir=\"ltr\">No pediatric clinical guidelines for evaluation or treatment of child functional dyspepsia are available.&nbsp;</p>\n<p dir=\"ltr\">The choice of therapy is outside the scope of this calculator and will depend on clinical context.</p>\n<p dir=\"ltr\">Some of the pharmacologic interventions have not been studied in children and/or adolescents and can only be used off-label.</p>\n<p><span id=\"docs-internal-guid-6fab29ae-7fff-ee99-5b84-55761ff0e072\"></p>\n<p dir=\"ltr\">*Available only through a special Investigational New Drug program (IND) given side effect profile, particularly possible QTc prolongation.</p>", "critical_actions_en": "<p><span id=\"docs-internal-guid-e610a664-7fff-23c2-bb12-c9fff33bca21\">This calculator should only be used in patients who do not have signs or symptoms suggestive of a structural, metabolic or other systemic cause of their symptoms based on clinical history, physical exam, and initial work-up.</p>"}, "about": {"formula_en": "<p dir=\"ltr\"><strong>Step 1. </strong>To fulfill the Rome IV criteria for child functional dyspepsia. Must fulfill both of the following &ge;4 days per month for with symptom onset &ge;2 months prior:</p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">&ge;1 of the following:</p>\n</li>\n<ol>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Postprandial fullness.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Early satiation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Epigastric pain or burning not associated with defecation.</p>\n</li>\n</ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">After appropriate evaluation, the symptoms cannot be fully explained by another medical condition.</p>\n</li>\n</ol>\n<p dir=\"ltr\"><strong>Step 2.</strong> If above criteria are met, then determine subtype.&nbsp;</p>\n<p dir=\"ltr\"><strong>Postprandial Distress Syndrome</strong></p>\n<p dir=\"ltr\">Must include one or both of the following:</p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bothersome postprandial fullness&nbsp; that prevents finishing a regular meal.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bothersome early satiation that prevents finishing a regular meal.</p>\n</li>\n</ol>\n<p dir=\"ltr\">*Supportive criteria includes upper abdominal bloating, postprandial nausea, or excessive belching.</p>\n<p dir=\"ltr\"><strong>Epigastric Pain Syndrome</strong></p>\n<p dir=\"ltr\">Must include one or both of the following:</p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bothersome (severe enough to interfere with normal activities) pain or burning localized to the epigastrium.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">The pain is not generalized or localized to other abdominal or chest regions and is not relieved by defecation or passage of flatus.</p>\n</li>\n</ol>\n<p dir=\"ltr\">*Supportive criteria include (a) burning quality of the pain but without a retrosternal component and (b) the pain commonly induced or relieved by ingestion of a meal but may occur while fasting.&nbsp;</p>\n<p dir=\"ltr\">**Note: patients may be positive for both postprandial distress syndrome AND epigastric pain syndrome</p>", "more_info_en": "", "evidence_based_medicine_en": "<p><span id=\"docs-internal-guid-92770ac2-7fff-3b20-3ff6-29b52d49c371\">The Rome IV criteria provide symptom-based guidelines by which child and adolescent disorders of the gut-brain interaction (DGBI) such as functional dyspepsia can be diagnosed. Prior iterations of the Rome criteria were based mostly on consensus, as research in child/adolescent DGBI was still largely lacking. An expanded evidence base of 10 years provided the basis for many of the recommendations of the child/adolescent committee for the newest Rome IV criteria published in 2016. For disorders still lacking scientific data, the committee used clinical experience and consensus among the expert committee members.</p>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104693/", "text": "Hyams J, Di lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130(5):1527-37."}], "Other References": [], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467078/", "text": "Boronat AC, Ferreira-maia AP, Matijasevich A, Wang YP. Epidemiology of functional gastrointestinal disorders in children and adolescents: A systematic review. World J Gastroenterol. 2017;23(21):3915-3927."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"name": "Beate Beinvogl, MD, MPH"}]}, "creator": [{"name": "Dr. Douglas Drossman", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>Douglas Drossman, MD, is professor emeritus of medicine and psychiatry at the University of North Carolina School of Medicine. He is founder, President Emeritus and Chief of Operations of the Rome Foundation. He is also the founder of the Drossman Center for the Education and Practice of Biopsychosocial Care and Drossman Consulting, LLC. Dr. Drossman has written over 500 articles and book chapters, has published two books, a GI procedure manual and a textbook of functional GI disorders (Rome I-IV), and serves on six editorial and advisory boards.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-douglas-drossman.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Drossman+DA%5BAuthor%5D"}}, {"name": "Dr. Lin Chang", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>Lin Chang, MD is responsible for the oversight and coordination of the Rome IV calculators on MDCalc. She is a Professor of Medicine at the Vatche and Tamar Manoukian Division of Digestive Diseases at UCLA and is a member of the Rome Foundation Board of Directors.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-lin-chang.jpg", "pubmedLink": "https://pubmed.ncbi.nlm.nih.gov/?term=Chang+L+%5Bauthor%5D"}}, {"name": "The Rome Foundation", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>The <a href=\"https://theromefoundation.org\" target=\"_blank\" rel=\"noopener\">Rome Foundation</a> is an independent not for profit 501(c) 3 organization that provides support for activities designed to create scientific data and educational information to assist in the diagnosis and treatment of Disorders of Gut-Brain Interaction (DGBI), also known as functional gastrointestinal (GI) disorders. Their mission is to improve the lives of people with DGBI. Over the last 3 decades, the Rome organization has sought to legitimize and update our knowledge of the DGBIs. This has been accomplished by bringing together scientists and clinicians from around the world to classify and critically appraise the science of GI function and dysfunction. This knowledge permits clinical scientists to make recommendations for diagnosis and treatment that can be applied in research and clinical practice. Diagnosis is based on the use of <a href=\"https://theromefoundation.org/rome-iv/rome-iv-criteria/\" target=\"_blank\" rel=\"noopener\">symptom-based criteria</a> which are used in clinical trials and daily practice. The list of Rome IV categories and the Chair and Co-Chair of each chapter committee are listed below.</p>\n<table border=\"\\&quot;0\\&quot;\" collapse;=\"\" width:=\"\" 100%;\\\"=\"\">\n<tbody>\n<tr>\n<td 31.1628%;\\\"=\"\"><strong>Committees</strong></td>\n<td 31.3097%;\\\"=\"\"><strong>Chair</strong></td>\n<td 31.3097%;\\\"=\"\"><strong>Co-Chair</strong></td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Esophageal Disorders</td>\n<td 31.3097%;\\\"=\"\">Ronnie Fass, MD</td>\n<td 31.3097%;\\\"=\"\">John Pandolfino, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Gastroduodenal Disorders</td>\n<td 31.3097%;\\\"=\"\">Nicholas J. Talley, MD, PhD, FRACP</td>\n<td 31.3097%;\\\"=\"\">Vincenzo Stanghellini, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Bowel Disorders</td>\n<td 31.3097%;\\\"=\"\">Fermin Mearin, MD</td>\n<td 31.3097%;\\\"=\"\">Brian Lacy, MD, PhD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Gallbladder and Sphincter of Oddi Disorders</td>\n<td 31.3097%;\\\"=\"\">Grace Elta, MD</td>\n<td 31.3097%;\\\"=\"\">Peter Cotton, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Centrally Mediated Disorders of Gastrointestinal Pain</td>\n<td 31.3097%;\\\"=\"\">Peter J. Whorwell, MD</td>\n<td 31.3097%;\\\"=\"\">Laurie Keefer, PhD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Anorectal Disorders</td>\n<td 31.3097%;\\\"=\"\">Adil E. Bharucha, MD, MBBS</td>\n<td 31.3097%;\\\"=\"\">Satish S. C. Rao, MD, PhD, FRCP</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Childhood Functional Gastrointestinal Disorders: Neonate/Toddler</td>\n<td 31.3097%;\\\"=\"\">Sam Nurko, MD</td>\n<td 31.3097%;\\\"=\"\">Marc A. Benninga, MD</td>\n</tr>\n<tr>\n<td 31.1628%;\\\"=\"\">Childhood Functional Gastrointestinal Disorders: Child/Adolescent</td>\n<td 31.3097%;\\\"=\"\">Carlo Di Lorenzo, MD</td>\n<td 31.3097%;\\\"=\"\">Jeffrey S. Hyams, MD</td>\n</tr>\n</tbody>\n</table>\n<p><b>Rome IV Diagnostic Criteria Chapters, Chairs and Co-Chairs</b></p>\n<p><b>Rome IV Editorial Board:</b> Douglas A. Drossman, MD, Senior Editor, Lin Chang, MD, William D. Chey, MD, John Kellow, MD, Jan Tack, MD, PhD, and William E. Whitehead, PhD.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/rome-foundation.png", "pubmedLink": "undefined"}}], "reviewer": {"expert_name": [{"name": "Samuel Nurko, MD, MPH"}]}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"subheading": "Must have \u22651 of the following:", "subheading_instructions": "For \u22654 days per month for \u22652 months prior", "type": "subheading"}, {"type": "toggle", "label_en": "Postprandial fullness", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "one"}, {"type": "toggle", "label_en": "Early satiation", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "two"}, {"type": "toggle", "label_en": "Epigastric pain or burning not associated with defecation", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "three"}, {"type": "toggle", "label_en": "After appropriate evaluation, the symptoms cannot be fully explained by another medical condition", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "four"}, {"subheading": "Additional criteria for child postprandial distress syndrome:", "subheading_instructions": "Must have the following for \u22652 months prior", "type": "subheading"}, {"type": "toggle", "label_en": "Bothersome postprandial fullness or early satiation that prevents finishing a regular meal", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "five"}, {"subheading": "Additional criteria for child epigastric pain syndrome:", "subheading_instructions": "Must have the following for \u22652 months prior", "type": "subheading"}, {"type": "toggle", "label_en": "Bothersome (severe enough to interfere with normal activities) pain or burning localized to the epigastrium", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "six"}, {"type": "toggle", "label_en": "The pain is not generalized or localized to other abdominal or chest regions and is not relieved by defecation or passage of flatus", "default": 0, "conditionality": "", "show_points": false, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "seven"}], "md5": "", "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "related_calcs": [{"calcId": 10331, "short_title_en": "Rome IV for Child Constipation", "slug": "rome-iv-diagnostic-criteria-child-functional-constipation"}, {"calcId": 10325, "short_title_en": "Rome IV for Child Nausea and Vomiting", "slug": "rome-iv-diagnostic-criteria-child-functional-nausea-vomiting"}, {"calcId": 10330, "short_title_en": "Rome IV for Child Abdominal Pain", "slug": "rome-iv-diagnostic-criteria-child-functional-abdominal-pain"}]}